These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1898785)

  • 1. Postthaw stability of fibrinogen in cryoprecipitate stored between 1 and 6 degrees C.
    Howard PL; Bovill EG; Golden E
    Transfusion; 1991 Jan; 31(1):30-1. PubMed ID: 1898785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of thawed pooled cryoprecipitate stored at refrigerated temperature for 24 hours.
    Soundar EP; Reyes M; Korte L; Bracey A
    Blood Transfus; 2018 Sep; 16(5):443-446. PubMed ID: 29106354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of von Willebrand factor and factor VIII in canine cryoprecipitate under various conditions of storage.
    Stokol T; Parry BW
    Res Vet Sci; 1995 Sep; 59(2):152-5. PubMed ID: 8525105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can storage of thawed cryoprecipitate be extended to more than six hours?
    Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA
    Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic characteristics of thawed, pooled cryoprecipitate stored for 35 days at refrigerated and room temperatures.
    Fenderson JL; Meledeo MA; Rendo MJ; Peltier GC; McIntosh CS; Davis KW; Corley JB; Cap AP
    Transfusion; 2019 Apr; 59(S2):1560-1567. PubMed ID: 30980741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of fibrinogen content in cryoprecipitate by temperature manipulation during plasma processing.
    Farrugia A; Grasso S; Douglas S; Harrap R; Oates A; Young I; James J; Whyte G
    Transfusion; 1992 Oct; 32(8):755-9. PubMed ID: 1412684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extending the post-thaw viability of cryoprecipitate.
    Thomson C; Sobieraj-Teague M; Scott D; Duncan E; Abraham S; Roxby D
    Transfusion; 2021 May; 61(5):1578-1585. PubMed ID: 33728705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Storage of thawed cryoprecipitated AHF is better at room temperature than at 1 degree C to 6 degrees C for factor VIII content.
    Saxena S; Odono V; Francis R; Shulman IA
    Arch Pathol Lab Med; 1991 Apr; 115(4):343-5. PubMed ID: 1901483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryoprecipitate as a reliable source of fibrinogen replacement.
    Ness PM; Perkins HA
    JAMA; 1979 Apr; 241(16):1690-1. PubMed ID: 430729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of coagulation protein activities in single units or pools of cryoprecipitate during storage at 20-24°C for up to 24 h.
    Sheffield WP; Bhakta V; Jenkins C
    Vox Sang; 2016 Jan; 110(1):12-9. PubMed ID: 26178178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postfiltration factor VIII and fibrinogen levels in cryoprecipitate stored at room temperature and at 1 to 6 degrees C.
    Spivey MA; Jeter EK; Lazarchick J; Kizer J; Spivey LB
    Transfusion; 1992 May; 32(4):340-3. PubMed ID: 1585439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen in cryoprecipitate and its relationship to factor VIII (AHF) levels.
    Ness PM; Perkins HA
    Transfusion; 1980; 20(1):93-6. PubMed ID: 7355478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.
    Green L; Backholer L; Wiltshire M; Platton S; Stanworth SJ; Cardigan R
    Transfusion; 2016 Jun; 56(6):1356-61. PubMed ID: 27019386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prolonged storage at 2°C-6°C for 120 h on the coagulation factors of thawed cryoprecipitate: Can we extend its shelf life post thaw beyond 4 h?
    Marik A; Philip J; Mallhi RS; Kushwaha N; Kumar S; Biswas AK; Yadav AK
    Asian J Transfus Sci; 2021; 15(2):146-150. PubMed ID: 34908745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing.
    Lokhandwala PM; O'Neal A; Patel EU; Brunker PAR; Gehrie EA; Zheng G; Kickler TS; Ness PM; Tobian AAR
    Transfusion; 2018 May; 58(5):1126-1131. PubMed ID: 29479708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposure.
    Hoffman M; Jenner P
    Am J Clin Pathol; 1990 May; 93(5):694-7. PubMed ID: 2327369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protocol for the preparation of cryoprecipitate and cryodepleted plasma.
    Sparrow RL; Greening DW; Simpson RJ
    Methods Mol Biol; 2011; 728():259-65. PubMed ID: 21468954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of pooled cryoprecipitate for treatment of hemophilia A in a home care program.
    Smith KJ; Hodges PA
    Transfusion; 1984; 24(6):520-3. PubMed ID: 6438840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.